卓越新能(688196.SH):擬投建“新增年產10萬噸烴基生物柴油和年產5萬噸脂肪酸項目”等等
格隆匯9月23日丨卓越新能(688196.SH)公佈,公司於2022年9月23日召開第四屆董事會第十二次會議,審議通過《關於投資建設“新增年產10萬噸烴基生物柴油和年產5萬噸脂肪酸項目”的議案》、《關於投資建設“年產10萬噸合成樹脂生產項目”的議案》、《關於投資設立全資子公司“龍巖致尚新材料有限公司”的議案》和《關於在新加坡投資設立全資子公司的議案》,投資情況如下:
1.投資事項一:公司投資3.8億元建設“新增年產10萬噸烴基生物柴油和年產5萬噸脂肪酸項目”;
2.投資事項二:公司投資5億元建設“年產10萬噸合成樹脂項目”,由公司全資子公司龍巖卓越合成樹脂有限公司作為項目實施主體;
3.投資事項三:公司設立全資子公司“龍巖致尚新材料有限公司”,註冊資金1億元,作為公司生物基增塑劑項目的實施主體;
4.投資事項四:公司在新加坡投資設立全資子公司,註冊資本不超過1000萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.